Cellectar Biosciences Inc (NASDAQ:CLRB)
| 2.24 Delayed Data As of Nov 29 |  +0.01 / +0.45%Today’s Change | 1.25 Today|||52-Week Range 3.15 | +30.99% Year-to-Date |
Five Year Financial Summary
| All Currency in US Dollars | 4 Quarter Trend | |||||
|---|---|---|---|---|---|---|
| Quarter 2 2018 | Quarter 3 2018 | Quarter 4 2018 | Quarter 1 2019 | |||
| Revenue and Income | Net Revenues | 0.00 | 0.00 | 0.00 | 0.00 | -- |
| Depreciation And Amortization | 16.9K | 15.9K | 32.2K | 32.7K | ||
| Operating Expenses | Gross Income | -16.9K | -15.9K | -32.2K | -32.7K | |
| General Expenses | 2.9M | 3.1M | 2.2M | 3.6M | ||
| Research And Development | 1.7M | 2.0M | 1.0M | 2.3M | ||
| Total Operating Expenses | 2.9M | 3.1M | 2.2M | 3.6M | ||
| Non-Operating Expenses | Operating Income | -2.9M | -3.1M | -2.2M | -3.6M | |
| Extraordinary Credit | 0.00 | 66.0K | 43.0K | 0.00 | ||
| Extraordinary Charge | -20.0K | 0.00 | 0.00 | -4.0K | ||
| Income Taxes, Minority Interest and Extra Items | Pre-Tax Income | -2.9M | -3.0M | -3.8M | -3.6M | |
| Preferred Dividend | 0.00 | -2.2M | -- | -- | ||
| Net Income | -2.9M | -3.0M | -3.8M | -3.6M | ||
| Shares To Calculate EPS | Shares To Calculate EPS | 1.7M | 3.2M | 4.7M | 4.8M | |
| Shares To Calculate EPS Diluted | 1.7M | 3.2M | 4.7M | 4.8M | ||
| Earnings Per Share | EPS | -$1.69 | -$1.65 | -$0.81 | -$0.76 | |
| EPS Diluted | -$1.69 | -$1.65 | -$0.81 | -$0.76 | ||
